140 filings
Page 5 of 7
8-K
ucz8trwdt1w567jrhaiq
6 Jun 17
Regulation FD Disclosure
12:00am
8-K
i5h06h5nb
21 Feb 17
Arch Therapeutics, Inc. $6.1 Million Registered Direct Offering
12:00am
8-K
0lgldzbjc 2jqx
16 Feb 17
Other Events
12:00am
8-K
dfz0l
2 Feb 17
Arch Therapeutics Announces Issuance of Method-of-Use Patent Covering Self-Assembling Peptidomimetics
12:00am
8-K
tbw040
31 Oct 16
Other Events
12:00am
8-K
fe19aahxx1xat
29 Sep 16
Entry into a Material Definitive Agreement
12:00am
8-K
mh92dwb1m5lk
15 Aug 16
Arch Therapeutics Reports AC5 Topical Hemostatic Device Meets Primary and Secondary Endpoints in First Clinical Study
12:00am
8-K
992u93t083u1
6 Jun 16
Arch Therapeutics Completes Patient Enrollment in Clinical Study of AC5
12:00am
8-K
0cvf4jg6g cm4l5z
2 Jun 16
Entry into a Material Definitive Agreement
12:00am
8-K
l628f0 2jcow
16 May 16
Arch Therapeutics Announces Issuance of Composition of Matter Patent Covering Self-Assembling Peptidomimetics
12:00am
8-K
94qabv
10 May 16
Arch Therapeutics Receives Notice of Allowance for Composition of Matter and Method of Use Patent Covering Solid Forms of Self-Assembling Peptides
12:00am
8-K
8d0i9g9wdjloml dv
6 May 16
Unregistered Sales of Equity Securities
12:00am
8-K
vvqo 64ao
25 Apr 16
Arch Therapeutics Receives Notice of Allowance for Patent Covering Systemic Applications for Self-Assembling Peptides
12:00am
8-K
seiq kzqee3
11 Apr 16
Arch Therapeutics Announces Notice of Allowance for Method of Use Patent Covering Uses of Self-Assembling Peptides
12:00am
8-K
0sbpxp3 2q
5 Apr 16
Arch Therapeutics Announces Notice of Allowance for Composition-of-Matter Patent Covering Self-Assembling Peptides
12:00am
8-K
wmamf6
22 Mar 16
Other Events
12:00am
8-K
cxxl6nkx6o7p88j8q5
14 Mar 16
Arch Therapeutics Reports Favorable Results for AC5 Surgical Hemostatic Device in Biocompatibility Testing Required for CE Mark
12:00am
8-K
m1vmrxeor4lzc62vd ac
9 Mar 16
Arch Therapeutics Receives ISO 13485 Certification for AC5
12:00am
8-K
tizbpvc924 0e
7 Mar 16
Other Events
12:00am
8-K
scbf 7r5n3fond
16 Dec 15
Arch Therapeutics Receives Clearance to Initiate Clinical Trial in Europe
12:00am